Skip to main content
Premium Trial:

Request an Annual Quote

You'd Think That Could Be Pooled into a Decent Clinical Trial

Over at Patent Docs, Donald Zuhn rounds up the money spent by pharma/biotech organizations to lobby the US federal government in the first quarter of this year. PhRMA tops the list with $3.6 million, while Pfizer and Amgen came in with a respectable $2.8 million and $2.5 million, respectively. It turns out that if you want to be properly schmoozed, you shouldn't spend time with Biogen -- that company only spent $200,000 to influence government. The post also includes an early look at second-quarter lobbying expenditures, indicating that many organizations are plowing even more funds into the effort.

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.